HARROW, INC. — Director's Dealing 2012

Mar 27, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-02-15

Reporting Person: Boll Andrew (VP, Accounting and Reporting)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (Right to Buy)	$0.736	2016-02-28	Common Stock (75000)		Direct

Footnotes

F1: The stock options, granted on February 1, 2012 and effective as of February 28, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Boll's options vest over a 3 year period at a strike price of $0.736, with 1/36th of the total number of options vesting each monthly period following the grant date of such options. As of the date of this Form 3 filing, options to purchase 2,083 shares of the Issuer's common stock are exercisable, but no options have been exercised.